Lung cancer

Results: 3256



#Item
21Website: www.tlcr.org Email: Print ISSN; Online ISSNTranslational Lung Cancer Research PUBLICATION ETHICS STATEMENT

Website: www.tlcr.org Email: Print ISSN; Online ISSNTranslational Lung Cancer Research PUBLICATION ETHICS STATEMENT

Add to Reading List

Source URL: tlcr.amegroups.com

    22Phase I/II trial of ensartinib+ (X-396) in patients with ALK+ non-small cell lung cancer (NSCLC): Correlation with plasma and tissue genotyping and response to therapy Leora Horn1, Heather Wakelee2, Karen Reckamp3, Saiam

    Phase I/II trial of ensartinib+ (X-396) in patients with ALK+ non-small cell lung cancer (NSCLC): Correlation with plasma and tissue genotyping and response to therapy Leora Horn1, Heather Wakelee2, Karen Reckamp3, Saiam

    Add to Reading List

    Source URL: www.resolutionbio.com

    - Date: 2017-01-03 23:04:13
      23Translational Lung Cancer Research INSTRUCTION FOR AUTHORS Thank you for your interest in Translational Lung Cancer Research. Please consult the following instructions to help you prepare your manuscript, and feel free t

      Translational Lung Cancer Research INSTRUCTION FOR AUTHORS Thank you for your interest in Translational Lung Cancer Research. Please consult the following instructions to help you prepare your manuscript, and feel free t

      Add to Reading List

      Source URL: tlcr.amegroups.com

      - Date: 2017-09-04 03:41:12
        24

        For Immediate Release January 27, 2015 Contact: Randall Hawkins, Team Draft Sends Super Bowl Challenge Winners to Super Bowl, Pro-Bowl and Taste of the NFL to Raise Lung Cancer Awareness

        Add to Reading List

        Source URL: www.chrisdraftfamilyfoundation.org

        - Date: 2015-04-02 00:51:03
          25Evolutionary dynamics of acid and VEGF production in tumours (+ measuring games in non-small cell lung cancer) Artem Kaznatcheev egtheory.wordpress.com

          Evolutionary dynamics of acid and VEGF production in tumours (+ measuring games in non-small cell lung cancer) Artem Kaznatcheev egtheory.wordpress.com

          Add to Reading List

          Source URL: egtheory.files.wordpress.com

          - Date: 2016-07-14 23:18:02
            26Proton Therapy for Patients with Lung Cancer Talk to your doctor about how Proton Therapy can help. Precision Therapy. Fewer side effects. Proton therapy is an advanced form of radiation cancer treatment that precisely t

            Proton Therapy for Patients with Lung Cancer Talk to your doctor about how Proton Therapy can help. Precision Therapy. Fewer side effects. Proton therapy is an advanced form of radiation cancer treatment that precisely t

            Add to Reading List

            Source URL: provisionproton.com

            - Date: 2014-06-03 13:58:57
              27DECISION AID SET STAGE IV Non-Small Cell Lung Cancer (NSCLC) Dear Clinician: This set of DECISION AIDS is based on ASCO’s Clinical Practice Guideline Update on Chemotherapy for Stage IV NSCLCASCO’s Guideline

              DECISION AID SET STAGE IV Non-Small Cell Lung Cancer (NSCLC) Dear Clinician: This set of DECISION AIDS is based on ASCO’s Clinical Practice Guideline Update on Chemotherapy for Stage IV NSCLCASCO’s Guideline

              Add to Reading List

              Source URL: www.asco.org

              - Date: 2013-01-18 15:35:17
                28A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab, Pemetrexed and Carboplatin in Patients with Non-Squamous Non-Small Cell Lung Cancer (NSCLC) 1 Stagg R,

                A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab, Pemetrexed and Carboplatin in Patients with Non-Squamous Non-Small Cell Lung Cancer (NSCLC) 1 Stagg R,

                Add to Reading List

                Source URL: s3.amazonaws.com

                - Date: 2014-09-25 16:14:56
                  29NOTCH3 Protein Expression and Outcome in Small Cell Lung Cancer (SCLC) and Therapeutic Targeting with Tarextumab (Anti-Notch 2/3)

                  NOTCH3 Protein Expression and Outcome in Small Cell Lung Cancer (SCLC) and Therapeutic Targeting with Tarextumab (Anti-Notch 2/3)

                  Add to Reading List

                  Source URL: posters.omed.s3.amazonaws.com

                  - Date: 2015-12-11 14:21:05
                    30Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe

                    Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe

                    Add to Reading List

                    Source URL: s3.amazonaws.com

                    - Date: 2014-09-25 16:16:58